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ABSTRACT: Tablet dissolution is strongly affected by swelling and solvent penetration into its matrix. A terahertz-pulsed imaging (TPI)
technique, in reflection mode, is introduced as a new tool to measure one-dimensional swelling and solvent ingress in flat-faced phar-
maceutical compacts exposed to dissolution medium from one face of the tablet. The technique was demonstrated on three tableting
excipients: hydroxypropylmethyl cellulose (HPMC), Eudragit RSPO, and lactose. Upon contact with water, HPMC initially shrinks to up
to 13% of its original thickness before undergoing expansion. HPMC and lactose were shown to expand to up to 20% and 47% of their
original size in 24 h and 13 min, respectively, whereas Eudragit does not undergo dimensional change. The TPI technique was used
to measure the ingress of water into HPMC tablets over a period of 24 h and it was observed that water penetrates into the tablet by
anomalous diffusion. X-ray microtomography was used to measure tablet porosity alongside helium pycnometry and was linked to the
results obtained by TPI. Our results highlight a new application area of TPI in the pharmaceutical sciences that could be of interest in
the development and quality testing of advanced drug delivery systems as well as immediate release formulations. C© 2015 The Authors.
Journal of Pharmaceutical Sciences published by Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci
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INTRODUCTION
Solid dosage forms are used to deliver active pharmaceuti-
cal ingredients (APIs) to treat a range of conditions, and ad-
vanced drug delivery formulations can be used to adjust the
drug release over short, long, or sustained periods of time at a
specified rate. In addition, solid dosage forms can be tailored
to work in specific parts of the gastrointestinal tract. There
are numerous methods for controlling the release of API with
immediate-release formulations and sustained-release matrix
formulations forming the focus of this investigation.1
For a range of matrix formulations, it has been demonstrated
that the interaction of the tablet with its surroundings can be
described by the so-called shrinking core mechanism and vari-
ants thereof.2 The shrinking core mechanism model describes
diffusion-controlled processes such as the interaction of the dis-
solutionmediumwith the solid and its ensuing physical conver-
sions. Mathematically, this process is described to occur layer
by layer until the drug release is complete,2 and although it
provides very good estimates for some formulations, it is not
suited for all formulations. The shrinking core mechanism can
establish whether diffusion or a reaction (chemical or physical)
is the rate-controlling mechanism; this is traditionally used on
particles with a fixed volume; therefore, numerous assumptions
have to be taken regarding the tablet and intraparticular ge-
ometries over the experimental procedure.2 More sophisticated
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analytical procedures to investigate the dissolution process of
tablets open the potential to devise better models that can be
used to predict and design tablet performance enabling formu-
lators to move from a largely empirical development process to
a refined design problem.
The changes, that take place in the dosage form upon contact
with the dissolution medium on the molecular and microstruc-
tural level, are complex and still not fully understood. For exam-
ple, the release of API from a swelling polymer matrix formu-
lation such as hydroxypropylmethyl cellulose (HPMC) involves
multiple steps on the molecular and microstructural level such
as diffusion, capillary action, polymer unwrapping, gel layer
formation, relaxation of compaction forces, among others.3 A
number of studies have described models of the swelling and
the diffusion of water into the tablet matrix as well as the sub-
sequent drug release. In particular, magnetic resonance imag-
ing (MRI) has been used noninvasively to provide a unique
insight into the water and drug diffusion and swelling kinet-
ics of HPMC formulations in detail. The rate of swelling in
different grades of HPMC was found to be different when com-
paring the radial to axial swelling and it was shown that the
tablets swell up to 300% of their original size in the radial
direction and 150% in the axial direction.4 It was also shown
that swelling is a result of two different physical processes:
during the hydration of HPMC tablet matrices, gel layer for-
mation occurs and at the same time relaxation of compaction
forces takes place.4–8 The developing gel layer acts as a dif-
fusion barrier that slows down further water uptake and in
turn alters the swelling kinetics of the tablet.9 Further, MRI
studies have also investigated this effect in commercial prod-
ucts that use HPMC as a swellable matrix former.10,11 In con-
trast to the nondestructive MRI analysis, a range of destruc-
tive methods have been used to analyze the dissolution process
in HPMC matrices including thermo gravimetric analysis,12,13
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near-infrared (NIR) spectroscopy, and infrared imaging,14–16
among other techniques. These techniques were used to assess
the dissolution as well as the ingress of water into the tablet
matrices.
Delalonde and Ruiz17 have shown that the swelling and dif-
fusion kinetics are influenced by the rate of water penetrating
the tablet matrix and the rate of air draining out. The changes
in pressure prompted by this fluid transport, coupled with the
movement of the solids within the matrix during the hydration
can cause the tablet to contract during the initial phases of the
experiments as observed previously.4 The rate of penetration of
water into the tablet matrix, the dissolution, water uptake and
release of API, as well as the swelling kinetics were found to be
dependent on the porosity of the tablet matrices.18 Numerous
techniques that work across a range of length scales can be
used to measure porosity: X-ray microcomputed tomography
(X:CT), helium pycnometry, mercury porosimetry, BET/BJH
analysis, and others. Using a combination of these techniques,
it is possible to extract both total porosity and pore size distri-
bution. This information can then be used to look at how tablet
voidage can affect the bulk transport mechanisms, which are
known to be dependent on the size, shape, and molecular inter-
action of the pores.19 Further work has investigated the effect
of compaction, polymer unwrapping, concentration of solvent,
and excipient as well as dissolution medium on the diffusion
process.8,20,21
A number of studies have demonstrated how experimental
data and theoretical models can be combined to describe the
diffusion and dissolution processes occurring within polymer-
based matrix tablets.3,7,8,22,23 On the basis of empirical data,
it is known that the rate of diffusion into and out of a tablet
can often be described by a power law and the Peppas–Sahlin
equation.22 Both the Peppas–Sahlin equation and the power
law are used to differentiate between Fickian diffusion and case
II relaxation,22 where Fickian transport is reliant on a concen-
tration gradient and case II transport on an activity gradient.24
Anomalous diffusion is a mode of transport that contains both
Fickian and case II characteristics, this mode of transport is
also described using the power law.22
The theoretical models discussed above were developed and
refined based on experimental data from MRI,4,7,11,25 NIR
imaging,26 infrared imaging,15,16 and spectroscopy27 as well as
other analytical tools. Terahertz imaging is a relatively re-
cent technique for pharmaceutical analysis. Its ability to pen-
etrate typical pharmaceutical tablets, the strong contrast it
can resolve based on subtle changes in refractive index within
structures and its high-time resolution make it an attractive
technique to investigate the microstructure of tablets.28 For
example, using terahertz time–domain spectroscopy, Bawuah
et al.29,30 demonstrated a method to calculate the total porosity
of a tablet in a transmission measurement. Terahertz-pulsed
imaging (TPI) has been widely used to nondestructively mea-
sure the coating thickness distribution of coated pharmaceuti-
cal dosage forms.31,32 It has also been used to measure the sur-
face density of uncoated tablets as well as tablet hardness.33
Previous research has demonstrated how MRI and TPI can
be combined to quantify coating stability before and after ac-
celerated storage conditions, and how changes in the coating
stability affect the dissolution process.11 Here, we demonstrate
that TPI can be used in a different context to resolve the pen-
etration of water into a tablet with time, while simultaneously
following how the dimensions of the tablet change.
MATERIALS AND METHOD
Materials
The samples were powder compacts of HPMC (K15m; Col-
orChem, Atlanta, Georgia), one of the most widely used com-
mercial swelling hydrophilic polymers used for sustained drug
release formulations34; Eudragit RSPO (Evonik, Hamburg,
Germany), which forms nonswelling matrices that can also be
used as a tablet matrix for sustained drug release; and lac-
tose "-monohydrate (Meggle, Wasserburg, Germany), which is
a soluble, filler, diluent, and bulking agent commonly found in
immediate-release formulations. Tablets were compressed to a
height of 1.5 mm with diameters of 10 or 13 mm depending on
the compaction technique.
Particle Size Measurements
The particles within the powders were measured using the
Morphologi G3S, which utilizes optical microscopy (Malvern In-
struments, Malvern, UK). The particle size distributions were
calculated using the Morphologi v8.11 software (Malvern In-
struments). The mean particle size, D50, of HPMC, Eudragit
RSPO, and Lactose were 16.9, 8.6, and 22.1 :m, respectively.
Compaction
Tablets were compressed to 1.5 mm thickness, either by using
a manual hydraulic press (Specac, Slough, UK) or a compaction
simulator (Huxley Bertram, Cambridge, UK), to diameters of
13 and 10 mm, respectively. The compaction simulator was in-
strumented to record the forces throughout the compaction pro-
cess. The amount of powder filled into the compression chamber
was adjusted such that the tablets were compressed to a final
height of 1.5 mm at 24 kN compaction force. In the compaction
simulator, the compression of the tablets was carried out over
a 2-s interval, where force was applied from the upper punch
and the lower punch was kept stationary resulting in the com-
paction profile shown in Figure 1. Approximately 0.140 g of
powder was required to compact tablets to height of 1.0 mm in
the case of HPMC, and for both Eudragit RSPO and HPMC,
approximately 0.250 g of powder is required to compact tablets
to a height of 1.50 mm.
On the manual tablet press, tablets were compressed over
a period of 5 min at a force of 24 kN. In contrast to the rapid
Figure 1. Compaction profile for the compression of Eudragit, lac-
tose, and HPMC using the compaction simulator. The dashed black
line corresponds to the readings from the lower punch and the red line
shows the forces acting on the upper punch.
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compression that was achieved on the compaction simulator,
this method leads to a more gradual compaction but through a
much less well-controlled process.
As the tablets are being compacted using the same force
but with two different tablet diameters, the tablets will be un-
dergoing different compaction pressures of 306 and 181 MPa
for the 10- and 13-mm diameter dies, respectively. This re-
sults in tablets of varying density and porosity. Tablets pro-
duced using a 10-mm die have a bulk density of 1150 ± 3.01
kg/m3, where the 13-mm die-produced tablets with a density of
1140 ± 9.46 kg/m3. Consequently, the resulting tablets have
subtle variations in porosity, where tablets undergoing a larger
applied pressure will have a pore size distribution with slightly
smaller pores. For the set of tablets produced, the variation was
found to be minor, but this change in porosity can potentially
induce changes in dissolution performance.35
As the samples are being compacted over different time
scales with compaction over a 5-min period versus a 2-s com-
paction process stronger plastic deformation of the powder par-
ticles is possible during the long compaction period, whereas
elastic deformation of the particles is likely to dominate during
the fast process. This will further affect the particle size and
shape distribution throughout the tablet matrix36 and hence
the pore size distribution and microstructure of the compacts.37
It would be expected that the pore size distribution would de-
crease as a result of plastic deformation and such changes
in microstructure would directly affect the disintegration
performance.
X-ray Microcomputed Tomography
The microstructure of the powder compacts was investigated
using a Skyscan 1172 (Bruker, Kontich, Belgium) X:CT instru-
ment. Using this technique, it is possible to nondestructively
measure the pore volume distributions of the macropores (with
diameters >4.55 :m) as well as analyzing the samples for the
presence of any cracks.
Samples were placed into a clear Perspex tube and were held
in place using spacers made from expanded polystyrene. The
Perspex tube is rotated at 0.25° increments of rotation over
360°, and the measured shadow projections were used to re-
construct cross-sections of the samples in the Perspex holder.
The Perspex tube and the air within the tube were used to cal-
ibrate the 8bit gray scale intensity during reconstruction be-
tween samples for subsequent threshold to ensure consistent
binarization of the cross-sections between air and excipient. Re-
construction of the shadow projections was performed using the
NRecon software (Skyscan, Version 1.6.9.3). The Dataviewer
software (Skyscan, Version 1.4.4) was used to align the re-
constructed datasets in x-, y-, and z-direction and then crop a
512 × 512 pixel region of interest traversing the center of the
tablet from top to bottom. ImageJ version 1.47i38 was used to
binarize the image and the BoneJ39 particle analyzer plug-in
was used to calculate pore volumes.
Helium Pycnometry
The density of the solidmatrix of the tablets was obtained using
the Accupyc 1330 Pycnometer (Micrometrics, Norcross, Geor-
gia). Before undergoing pycnometry, samples were weighed.
The 10-mm diameter samples are placed into a 1-cm3 sam-
ple cup, whereas the 13-mm tablets were placed into a 10-cm3
sample cup. The sample chamber was pressurized to 10 bar
Figure 2. (a) Schematic diagram of the sample holder. (b) Schematic
describing the analytical technique, where n1 represents the refractive
index of air, n2 represents HPMC, n3 represents water, and 2i is the
incident angle of the terahertz beam.
with helium and this was repeated 30 times, after which a den-
sity reading for the solid matrix was recorded (particle density,
Dp). Using these data, the density of the void space within the
tablet was determined and the porosity was calculated.
Diffusion Analysis Using TPI
The swelling and diffusion kinetics of dissolution medium in
the tablets were measured using a modified TPI Imaga 2000
(Teraview Ltd., Cambridge, UK). A detailed description of the
general principle behind the measurement technique was pre-
sented earlier.40 The TPI has a spectral range of 60 GHz to
3 THz, corresponding to wavelengths of 5.00 to 0.09 mm. High-
resistivity silicon lenses and silicon probe optics focus the tera-
hertz radiation to a diffraction-limited spot (200 :m diameter
at a distance of 7 mm in front of the optics), where the sample
is placed. A homemade sample holder (Fig. 2a) was used to fix
the sample into place and expose it to water on one face while
allowing for TPI reflection measurements through the opposite
face.
In this setup, the entire surface of the radial band of the
tablet is sealed from water, limiting the exposure from water
to the back axial face of the tablet. By propagating a terahertz
pulse into the tablet through its dry face, the one-dimensional
diffusion of the dissolution medium can be studied in reflection
mode, as shown in Figure 2b. This set up restricts the swelling
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Figure 3. Raw and deconvolved waveforms. (a) and (c) Raw waveforms obtained using the TPI before and after water is in contact with the
tablet, respectively. (b) and (d) Deconvolved waveforms corresponding to (a) and (c), respectively. The reflection from the front surface of the tablet
is marked as t1, whereas t2 refers to the response from the back surface of the tablet.
of the axial surface at outer circumference to ensure the tablet
is held in place; the majority of the front axial surface is free
to swell as it is exposed to air. Like most polymers, HPMC is
semitransparent to terahertz radiation and it is hence possi-
ble to assess physical changes within the tablet matrix that
result in a change of its refractive index. At every point in the
sample where the refractive index changes, a proportion of the
radiation will be reflected, the amplitude of which will be pro-
portional to the change in refractive index as defined by the
Fresnel equations.40 In our measurements, 15 reflected wave-
forms are measured per second, and the waveforms are aver-
aged depending on the duration of the diffusion process. For
the experiments using sustained-release excipients, the diffu-
sion process is monitored for a number of hours, whereas for
lactose water breaches the front face of the tablet within 13
min, at which point the experiment is stopped. Therefore, 30
waveforms were averaged for the HPMC and Eudragit experi-
ments and no averaging was performed for the lactose samples.
To facilitate the analysis, the waveforms were deconvolved
mathematically to highlight the interfaces and remove noise.41
This was achieved by dividing the sample response by the ref-
erence and multiplying by the Fourier transform of the filter in
the frequency domain as shown in Eq. (1),42 where FFT is the
fast Fourier transform.
Deconvolvedwaveform = FFT−1
[
FFT (sample)
FFT (reference)
× f DG
]
. (1)
The reference waveforms used in these experiments refer to
a reflection from the dry tablet before the tablet is exposed
to water. The filter used was a double Gaussian filter that
uses a high-frequency and low-frequency bandpass filter to re-
move background noise and this is mathematically described in
Eq. (2),41 where fDG denotes the double Gaussian filter, t is time,
and HF and LF are the high-frequency and low-frequency lim-
its, respectively. Themathematical product is then transformed
back to the time domain using an inverse Fourier transform:
f DG (t) = exp
(
− t
2
HF2
)
− exp
(
− t
2
LF2
)
. (2)
Figure 3a is an example of a raw waveform produced from
the dry tablet, Figure 3b shows an example of a waveform af-
ter deconvolution, Figure 3c is an example of a wetted tablet,
and Figure 3d is its deconvolution. As in the raw waveform,
each feature in the deconvolved waveform still originates from
a change in refractive index but in this representation the in-
terfaces are now easier to identify and to assign, as shown in
Figure 3c: the first reflection t1 represents the front surface
of the tablets, where the refractive index changes between air
and the polymer. As air has a lower refractive index compared
with the polymer, the peak is positive. The second peak t2 is a
response arising from the change of refractive index between
dry matrix former and water where the wet material has the
higher refractive index because of the inherently higher refrac-
tive index of water n = 2.443 compared with the porous polymer
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compact n < 1.5. This peak propagates over time, and repre-
sents a penetration front.
The intensity of these features is dependent on the amount
of radiation that is reflected back to the emitter. This can be
calculated using Fresnel’s equation as shown in Eq. (3), where
r is the reflectivity.
r =
(
nt − ni
nt + ni
)2
(3)
The distance of each refractive index interface from the emit-
ter can be calculated using Eq. (4), where n1 is the refractive
index of the sample, c is the speed of light in vacuum, and t is
the time delay in seconds.
d= n1ct
2
. (4)
Both the deconvolved and raw waveforms are analyzed in
two ways: the first analysis is tracking the movement of the
front surface (t1) as water is entering the tablet at the back
face, thus measuring the swelling kinetics of the tablets. The
second analysis is to monitor and quantify the formation of any
new features and their movements within the tablet matrix
that can be assigned to the diffusion front.
RESULTS AND DISCUSSION
Microstructure Analysis
The X:CT data were analyzed manually by inspecting each
reconstructed xy-slice image of all samples to detect any struc-
tural defects such as cracks within the tablet (Figure 5). In
addition to revealing cracks, the images clearly resolve grain
patterns within the tablets, which were found to qualitatively
differ between the three excipients as shown in Figure 4. Suf-
ficiently large pore spaces to be resolved by X:CT were found,
which were used to quantify the pore space in each tablet
sample.
Figure 4. Cross-section at the center of a HPMC tablet produced
using the compaction simulator. In this sample, a crack propagates
into the tablet matrix in the radial direction and it extends from the
top surface of the tablet to the bottom. The color bar shows the gray
scale of the image in arbitrary units (a.u.).
There are clear differences in the shapes of the grain in the
compactsmade from the three different excipients, in particular
betweenHPMC and Eudragit. The grain patterns in the lactose
tablets are much smaller and occur at a much lower frequency
in comparison to Eudragit and HPMC; this is a result of the
tablet reaching its solid limit. The grain boundaries can be
a result of the particle shape prior to compaction as well as
the mechanical properties of the particles.44 In Figure 4, the
X-ray cross-sections contain ring artifacts, resulting from errors
produced using the back projection algorithm, which increase
with the perpendicular distance from the central slice and the
filters used in reconstruction; these enhance frequencies, for
example, high frequencies produced by changing sensitivities
in adjacent detector elements in the charge coupled device.45
This is a systematic error in the reconstruction and does not
result in significant errors in the subsequent analysis.
For further analysis, a region of 512 × 512 pixels at the cen-
ter of the tablet was used to carry out a quantitative pore size
analysis in order to calculate the pore size distribution of the
samples, the results of which are shown in Figure 6. Unsur-
prisingly, the tablets produced using the compaction simulator
exhibited a more consistent pore distribution compared with
the ones produced using the hydraulic press that reflects the
more controlled method of compaction in the compaction simu-
lator that yields a more reproducible microstructure. The high-
est degree of variation was seen in the 1.0-mm thick HPMC
samples.
In all five cases, 4%–5% of the total pore volume are at-
tributed to pore networks with volumes of 1500 :m3 or less.
In our samples, the HPMC tablets have the largest number of
macropores, whereas lactose shows the lowest and is approach-
ing its solid limit at this compaction force46 (Table 1). Note that
typically lactose is compacted at 2–15 kN.47
The particle densities (DD) are calculated using the helium
pycnometry technique, then using porosity = (1−Db/DD), it is
possible to calculate the porosity of the powder compacts. Table
1 lists the particle densities, bulk densities, and the porosities
calculated using the above equation.
The measured porosities of HPMC, lactose, and Eudragit are
in good agreementwith literature values.46,48 It is clear that lac-
tose and Eudragit form more porous structures in comparison
to HPMC when using the compaction process chosen for this
study.
The porosity and structural data collected are typically used
as manufacturing criteria in the pharmaceutical industry, as
they are used as an indicator of the drug delivery systems per-
formance. In the future, we aim to link this information to the
swelling and diffusion kinetics measured used by TPI, which
can be used as a link between microstructure and dissolution
studies.
Analysis of Diffusion and Swelling Kinetics with TPI
Figure 7 presents a waterfall plot of the time–domain wave-
forms obtained for the HPMC tablet matrix when in contact
with water. The three features discussed in Figure 3 are clearly
observed. By following the movement of the front and back
surface, the swelling kinetics can be extracted. From the wave-
forms, it is apparent that the overall tablet thickness remains
constant over the first 6 h; for the remainder of the experiment,
the tablet dimensions gradually shrink. After 2.5 h, the diffu-
sion front can be resolved, because of a change in refractive
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Figure 5. Reconstructed cross-sections of the X:CT images of (a) HPMC, (b) Eudragit, and (c) lactose; all prepared with the compaction
simulator. The color bar shows the gray scale of the image in arbitrary units (a.u.).
, , , ,
, ,, ,
Figure 6. Pore size distributions measured using X:CT. (a) 1.50 mm thick sample of HPMC prepared on the compaction simulator;
(b) 1.50 mm thick sample of HPMC prepared using the manual hydraulic press; (c) 1.00 mm thick sample of HPMC prepared using the manual
hydraulic press; and (d) 1.50 mm Eudragit sample compressed using the compaction simulator. The error bars represent the SDs between three
separate samples analyzed using X:CT.
index between the hydrated polymer and dry polymer, which
is propagating from the wetted tablet surface to the front dry
surface.
Figure 8 shows the initial expansion profiles for the different
HPMC samples produced. HPMC samples compressed using
the compaction simulator exhibited the largest scale of contrac-
tion, where the front face can contract up to 13% of the total
tablet thickness (Fig. 8a). The HPMC tablets produced using
the manual hydraulic press (Fig. 8b) exhibited very little vari-
ation in their geometry, with a total magnitude up to 4% of the
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Table 1. Bulk Densities, Particle Densities, and Porosities of the Powder Compact Samples
Sample Mass (g) Bulk Density (g/cm3) Particle Density (g/cm3) > (%) " (%) SD (g/cm3)
HPMC (HB) 0.1305 1.11 1.35 5.41 18.3 3.00 × 10−4
HPMC (HM) 0.2305 1.16 1.39 5.54 16.6 4.00 × 10−4
HPMC (HMT) 0.1331 0.669 1.47 10.1 54.5 1.00 × 10−4
Lactose 0.1685 1.43 2.52 3.00 × 10−4 43.3 8.32 × 10−3
Eudragit 0.1152 0.978 2.03 12.7 43.1 3.42 × 10−3
> is the void space calculated using the X:CT and " is the porosity calculated using helium pycnometry. HPMC (HB) are tablets produced using the compaction
simulator, HPMC (HM) are tablets that are compacted using the manual hydraulic press, HPMC (HMT) are tablets produced using the manual press with a thickness
of 1 mm, lactose refers to tablets that contain lactose, and Eudragit refers to tablets containing only Eudragit RSPO. The standard deviations refer to the bulk
densities as measured by helium pycnometry (n=3).
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Figure 7. Time–domain waveforms acquired over a period of 24 h
during exposure of HPMC to water. Each waveform is offset vertically
by 0.0325 a.u. (arbitrary units).
total tablet thickness, producing the most reproducible results.
The 1.00-mm samples (Fig. 8c) show the greatest variation,
with minimal swelling but the largest magnitude of expansion.
One explanation for these changes is the organization of
the material within the tablet matrix as discussed by Picker.36
The contraction processes observed using the TPI occur over
a shorter period and this possibly because of the hydration of
the tablet matrices accelerating the process. More work is re-
quired to fully understand what the underlying causes of these
contractions are. From the experimental data that were ac-
quired from the HMPC sample over 24 h, it was possible to
identify a diffusion front in the HPMC matrix. Figure 7 shows
Figure 9. Diffusion front analysis in HPMC; the black points are the
diffusion front position at a time t and the red lines is fit to Eq. (5).
the contrast between wetted polymer and dry polymer within
the matrix. Following this, response over time can be used to
track the diffusion front. This movement can then be related to
Eq. (5), which can elucidate the principle control mechanism of
the diffusion:
f (t) = ktm (5)
Figure 9 is the comparison of the experimentally measured
diffusion front to theoretical data. When fitting with Eq. (3), m
is equal to 0.581, with an R squared value of 0.983, and root-
mean-squared error of 0.006 mm. This m value is indicative of
anomalous diffusion.20
Figure 8. Swelling profiles over a 2.5-h period, where (a) is a 1.5-mm sample of HPMC prepared using a compaction simulator, (b) is a 1.5-mm
sample of HPMC prepared on a manual hydraulic press; and (c) is a 1.00-mm HPMC sample also prepared on the manual hydraulic press. The
error bars are SDs between three experimental repeats.
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Figure 10. Time–domain waveforms acquired over a period of 4 h
during exposure of Eudragit to water. Each waveform is offset verti-
cally by 0.08 a.u. (arbitrary units). (a) A figure of the raw waveforms
obtained; (b) the waveforms after deconvolution.
Eudragit is a nonswelling and soluble compound; therefore,
when in contact with water it should not swell or disintegrate.
Figure 10 shows that there is minimal movement in the Eu-
dragit samples, as expected for this polymer. The matrix is not
changing its dimensions and remains stable over a period of
4 h. The use of methacrylate copolymers such as Eudragit has
been reported to lack the presence of a swelling and gel form-
ing layer and hence matrices containing these compounds are
controlled by erosion49 and this is demonstrated in the results
obtained using the TPI.
In contrast to the HPMC and Eudragit matrices, the diffu-
sion process is rapid in lactose. The tablet matrix is steadily
swelling, until water breaks through the front face of the tablet
where a rapid expansion of the tablet geometry occurs. This is
expected as lactose is often used as a disintegrant.
Figure 11 shows how the lactose waveforms transform over
time when in contact with water. When the raw waveforms
are deconvolved using the dry tablet as the reference, the high
frequency oscillations in the waveforms disappear. After 30 s
when in contact with water, these oscillations reappear. The
oscillations are a direct consequence of the vibrational features
observed in crystalline organic molecular materials.50 When
lactose tablets are hydrated, they undergo expansion, until they
are completely saturated, taking approximately 13 min. At this
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Figure 11. Time–domain waveforms acquired over a period of 13 min
during exposure of lactose to water. Each waveform is offset vertically
by 0.08 a.u. (arbitrary units). (a) A figure of the raw waveforms ob-
tained; (b) the waveforms after deconvolution.
point, the tablet collapse and the front surface of the tablet
rupture, as demonstrated in Figure 11.
CONCLUSIONS
We have demonstrated that terahertz imaging can be used as
a powerful tool to investigate diffusion within pharmaceutical
powder compacts. It utilizes the contrast between water and
polymers to track diffusion while simultaneously assessing the
swelling of the polymer matrices.
When in contact with water, the HPMC tablets contract, by
approximately 5% of their initial thickness. The tablets then
enter a rapid expansion phase where they can expand to up to
20% of their original thickness. Analyzing the diffusion front
in HPMC shows that the diffusion of water into the tablets is
primarily anomalous diffusion that indicates a mixture of both
Fickian diffusion and control from polymer unwrapping. Us-
ing the Peppas–Sahlin relation has shown that the bulk of the
diffusion is Fickian. Analysis on Eudragits has demonstrated
that the matrix remains stable and unchanged when in contact
with water; in contrast, lactose shows steady swelling immedi-
ately before water breaks through the front face after 13 min.
Using pycnometry and X-ray microtomography, these effects
were related to the tablet microstructure, which is a step
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toward understanding how microstructure and compaction af-
fect diffusion in powder compacts.
Experimental data collected in this study have been carried
out using a proof of concept apparatus. The set up will be mod-
ified to produce more reproducible results, by introducing flow
into the set up, to ensure a constant pressure as well as provid-
ing a more robust system.
There are still many unanswered questions; the complexity
of the swelling kinetics in HPMC requires further study and
validation using nuclear magnetic resonance and NIR imaging.
Different dissolution mediums will be analyzed including low
pH solutions, fasting-state small intestinal fluid, and fed-state
small intestinal fluid.
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